{"id":1336,"date":"2005-12-01T12:09:00","date_gmt":"2005-12-01T11:09:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/betarezeptoren-blocker-und-clopidogrel-beim-akuten-myokardinfarkt-commit-eine-megastudie-aus-china"},"modified":"2005-12-01T12:09:00","modified_gmt":"2005-12-01T11:09:00","slug":"betarezeptoren-blocker-und-clopidogrel-beim-akuten-myokardinfarkt-commit-eine-megastudie-aus-china","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/betarezeptoren-blocker-und-clopidogrel-beim-akuten-myokardinfarkt-commit-eine-megastudie-aus-china","title":{"rendered":"Betarezeptoren-Blocker und Clopidogrel beim akuten Myokardinfarkt \u2013 COMMIT, eine Megastudie aus China"},"content":{"rendered":"<p>Im Lancet vom 5. November 2005 wird aus China \u00fcber zwei Studien an 45852 Patienten mit akutem Myokardinfarkt in 1250 Krankenh\u00e4usern berichtet (1, 2). Sie wurden zweifach randomisiert doppeltblind mit Metoprolol oder Plazebo und Clopidogrel oder Plazebo im Mittel etwa 20 Tage lang behandelt. Das logistische Zentrum war die Clinical Trial Service and Epidemiological Studies [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im Lancet vom 5. November 2005 wird aus China \u00fcber zwei Studien an 45852 Patienten mit akutem Myokardinfarkt in 1250 Krankenh\u00e4usern berichtet (1, 2). Sie wurden zweifach randomisiert doppeltblind mit Metoprolol oder Plazebo und Clopidogrel oder Plazebo im Mittel etwa 20 Tage lang behandelt. Das logistische Zentrum war die Clinical Trial Service and Epidemiological Studies [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[778,777,131,3220,73,3219,71,633,65],"class_list":["post-1336","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-beta-agonisten","tag-beta-sympathikomimetika","tag-betarezeptoren-blocker","tag-clarity-timi-28-studie","tag-clopidogrel","tag-commit-studie","tag-herzinfarkt","tag-metoprolol","tag-myokardinfarkt"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1336"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1336\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}